Related references
Note: Only part of the references are listed.Clinical validation of the novel HDAC6 radiotracer [18F]EKZ-001 in the human brain
Michel Koole et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2021)
Depending on the stress, histone deacetylase inhibitors act as heat shock protein co-inducers in motor neurons and potentiate arimoclomol, exerting neuroprotection through multiple mechanisms in ALS models
Rachel Kuta et al.
CELL STRESS & CHAPERONES (2020)
A patent review of histone deacetylase 6 inhibitors in neurodegenerative diseases (2014-2019)
Sida Shen et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2020)
Radiosynthesis and preliminary evaluation of an 18F-labeled tubastatin A analog for PET imaging of histone deacetylase 6
Tetsuro Tago et al.
JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS (2020)
Translation of HDAC6 PET Imaging Using [18F]EKZ-001-cGMP Production and Measurement of HDAC6 Target Occupancy in Nonhuman Primates
Sofie Celen et al.
ACS CHEMICAL NEUROSCIENCE (2020)
HDAC10 deletion promotes Foxp3+ T-regulatory cell function
Satinder Dahiya et al.
SCIENTIFIC REPORTS (2020)
HDAC1 inhibition ameliorates TDP-43-induced cell death in vitro and in vivo
Simona Sanna et al.
CELL DEATH & DISEASE (2020)
Epigenetics in amyotrophic lateral sclerosis: a role for histone post-translational modifications in neurodegenerative disease
Seth A. Bennett et al.
TRANSLATIONAL RESEARCH (2019)
Histone deacetylase 4 protects from denervation and skeletal muscle atrophy in a murine model of amyotrophic lateral sclerosis
Eva Pigna et al.
EBIOMEDICINE (2019)
Deacetylation of Miro1 by HDAC6 blocks mitochondrial transport and mediates axon growth inhibition
Ashley L. Kalinski et al.
JOURNAL OF CELL BIOLOGY (2019)
Evaluation of [11C]KB631 as a PET tracer for in vivo visualisation of HDAC6 in B16.F10 melanoma
Koen Vermeulen et al.
NUCLEAR MEDICINE AND BIOLOGY (2019)
Class I and II histone deacetylase expression is not altered in human amyotrophic lateral sclerosis: Neuropathological and positron emission tomography molecular neuroimaging evidence
Amanda M. Dios et al.
MUSCLE & NERVE (2019)
Neuroepigenetic signatures of age and sex in the living human brain
Tonya M. Gilbert et al.
NATURE COMMUNICATIONS (2019)
Restoration of histone acetylation ameliorates disease and metabolic abnormalities in a FUS mouse model
Elisabeth Rossaert et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2019)
THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Transporters
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2019)
THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Ion channels
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2019)
THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Introduction and Other Protein Targets
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2019)
THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Enzymes
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2019)
Acetylation of intrinsically disordered regions regulates phase separation
Makoto Saito et al.
NATURE CHEMICAL BIOLOGY (2019)
A Chemical Screen Identifies Compounds Limiting the Toxicity of C9ORF72 Dipeptide Repeats
Alba Corman et al.
CELL CHEMICAL BIOLOGY (2019)
Molecular imaging HDACs class Ila expression-activity and pharmacologic inhibition in intracerebral glioma models in rats using PET/CT/(MRI) with [18F]TFAHA
Maxwell T. Laws et al.
SCIENTIFIC REPORTS (2019)
Energy metabolism in ALS: an underappreciated opportunity?
Tijs Vandoorne et al.
ACTA NEUROPATHOLOGICA (2018)
HDAC8 regulates neural differentiation through embryoid body formation in P19 cells
Syouichi Katayama et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
Zinc binding groups for histone deacetylase inhibitors
Lei Zhang et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2018)
Complex neuroprotective and neurotoxic effects of histone deacetylases
Elizabeth A. Thomas et al.
JOURNAL OF NEUROCHEMISTRY (2018)
Randomized, double-blind, placebo-controlled trial of arimoclomol in rapidly progressive SOD1 ALS
Michael Benatar et al.
NEUROLOGY (2018)
Effects of Class II-Selective Histone Deacetylase Inhibitor on Neuromuscular Function and Disease Progression in SOD1-ALS Mice
Daniela Buonvicino et al.
NEUROSCIENCE (2018)
Programming and Regulation of Metabolic Homeostasis by HDAC11
Lei Sun et al.
EBIOMEDICINE (2018)
Acetylation state of RelA modulated by epigenetic drugs prolongs survival and induces a neuroprotective effect on ALS murine model
Lorenzo Schiaffino et al.
SCIENTIFIC REPORTS (2018)
SIRT1 deacetylase in aging-induced neuromuscular degeneration and amyotrophic lateral sclerosis
Adrianna Z. Herskovits et al.
AGING CELL (2018)
Neurodegenerative Disease Proteinopathies Are Connected to Distinct Histone Post-translational Modification Landscapes
Karen Chen et al.
ACS CHEMICAL NEUROSCIENCE (2018)
A De Novo RAPGEF2 Variant Identified in a Sporadic Amyotrophic Lateral Sclerosis Patient Impairs Microtubule Stability and Axonal Mitochondria Distribution
Keunjung Heo et al.
EXPERIMENTAL NEUROBIOLOGY (2018)
Could Sirtuin Activities Modify ALS Onset and Progression?
Bor Luen Tang
CELLULAR AND MOLECULAR NEUROBIOLOGY (2017)
Gene discovery in amyotrophic lateral sclerosis: implications for clinical management
Ammar Al-Chalabi et al.
NATURE REVIEWS NEUROLOGY (2017)
Subcellular Distribution of HDAC1 in Neurotoxic Conditions Is Dependent on Serine Phosphorylation
Yunjiao Zhu et al.
JOURNAL OF NEUROSCIENCE (2017)
Effect of Class II HDAC inhibition on glutamate transporter expression and survival in SOD1-ALS mice
Andrea Lapucci et al.
NEUROSCIENCE LETTERS (2017)
RBM45 competes with HDAC1 for binding to FUS in response to DNA damage
Juanjuan Gong et al.
NUCLEIC ACIDS RESEARCH (2017)
HDAC6 inhibition reverses axonal transport defects in motor neurons derived from FUS-ALS patients
Wenting Guo et al.
NATURE COMMUNICATIONS (2017)
HDAC6 Brain Mapping with [18F] Bavarostat Enabled by a RuMediated Deoxyfluorination
Martin G. Strebl et al.
ACS CENTRAL SCIENCE (2017)
Loss of SIRT2 leads to axonal degeneration and locomotor disability associated with redox and energy imbalance
Stephane Fourcade et al.
AGING CELL (2017)
Modelling amyotrophic lateral sclerosis: progress and possibilities
Philip Van Damme et al.
DISEASE MODELS & MECHANISMS (2017)
Tauroursodeoxycholic acid in the treatment of patients with amyotrophic lateral sclerosis
A. E. Elia et al.
EUROPEAN JOURNAL OF NEUROLOGY (2016)
Exploration of the labeling of [11C]tubastatin A at the hydroxamic acid site with [11C]carbon monoxide
Shuiyu Lu et al.
JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS (2016)
The Role of Skeletal Muscle in Amyotrophic Lateral Sclerosis
Jean-Philippe Loeffler et al.
BRAIN PATHOLOGY (2016)
Toxic gain of function from mutant FUS protein is crucial to trigger cell autonomous motor neuron loss
Jelena Scekic-Zahirovic et al.
EMBO JOURNAL (2016)
MEF2D and MEF2C pathways disruption in sporadic and familial ALS patients
Alessandro Arosio et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2016)
Expression of microRNAs in human post-mortem amyotrophic lateral sclerosis spinal cords provides insight into disease mechanisms
Claudia Figueroa-Romero et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2016)
Unraveling gene expression profiles in peripheral motor nerve from amyotrophic lateral sclerosis patients: insights into pathogenesis
Nilo Riva et al.
SCIENTIFIC REPORTS (2016)
Protective effect of valproic acid on cultured motor neurons under glutamate excitotoxic conditions. Ultrastructural study
Ewa Naganska et al.
FOLIA NEUROPATHOLOGICA (2015)
Filamin A Is Required in Injured Axons for HDAC5 Activity and Axon Regeneration
Yongcheol Cho et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Histone deacetylase 6 delays motor neuron degeneration by ameliorating the autophagic flux defect in a transgenic mouse model of amyotrophic lateral sclerosis
Sheng Chen et al.
NEUROSCIENCE BULLETIN (2015)
Cytoplasmic sequestration of FUS/TLS associated with ALS alters histone marks through loss of nuclear protein arginine methyltransferase 1
Michael Tibshirani et al.
HUMAN MOLECULAR GENETICS (2015)
A novel small molecule HSP90 inhibitor, NXD30001, differentially induces heat shock proteins in nervous tissue in culture and in vivo
Jieun R. C. Cha et al.
CELL STRESS & CHAPERONES (2014)
ALS-associated mutation FUS-R521C causes DNA damage and RNA splicing defects
Haiyan Qiu et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
In Vivo Imaging of Histone Deacetylases (HDACs) in the Central Nervous System and Major Peripheral Organs
Changning Wang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
MS-275, a Class I histone deacetylase inhibitor, protects the p53-deficient mouse against ischemic injury
Sean P. Murphy et al.
JOURNAL OF NEUROCHEMISTRY (2014)
State of play in amyotrophic lateral sclerosis genetics
Alan E. Renton et al.
NATURE NEUROSCIENCE (2014)
Antidepressant-Like Properties of Novel HDAC6-Selective Inhibitors with Improved Brain Bioavailability
Jeanine Jochems et al.
NEUROPSYCHOPHARMACOLOGY (2014)
Tissue-specific deregulation of selected HDACs characterizes ALS progression in mouse models: pharmacological characterization of SIRT1 and SIRT2 pathways
C. Valle et al.
CELL DEATH & DISEASE (2014)
SIRT1 overexpression ameliorates a mouse model of SOD1-linked amyotrophic lateral sclerosis via HSF1/HSP70i chaperone system
Seiji Watanabe et al.
MOLECULAR BRAIN (2014)
Overexpression of human wild-type FUS causes progressive motor neuron degeneration in an age- and dose-dependent fashion
Jacqueline C. Mitchell et al.
ACTA NEUROPATHOLOGICA (2013)
Muscle histone deacetylase 4 upregulation in amyotrophic lateral sclerosis: potential role in reinnervation ability and disease progression
Gaelle Bruneteau et al.
BRAIN (2013)
Injury-Induced HDAC5 Nuclear Export Is Essential for Axon Regeneration
Yongcheol Cho et al.
CELL (2013)
Hdac6 deletion delays disease progression in the SOD1G93A mouse model of ALS
Ines Taes et al.
HUMAN MOLECULAR GENETICS (2013)
HDAC6 Regulates Mutant SOD1 Aggregation through Two SMIR Motifs and Tubulin Acetylation
Jozsef Gal et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
The functional interactome landscape of the human histone deacetylase family
Preeti Joshi et al.
MOLECULAR SYSTEMS BIOLOGY (2013)
Interaction of FUS and HDAC1 regulates DNA damage response and repair in neurons
Wen-Yuan Wang et al.
NATURE NEUROSCIENCE (2013)
SIRT1 collaborates with ATM and HDAC1 to maintain genomic stability in neurons
Matthew M. Dobbin et al.
NATURE NEUROSCIENCE (2013)
Mutant SOD1G93A triggers mitochondrial fragmentation in spinal cord motor neurons: Neuroprotection by SIRT3 and PGC-1α
Wenjun Song et al.
NEUROBIOLOGY OF DISEASE (2013)
Differential Sirtuin Expression Patterns in Amyotrophic Lateral Sclerosis (ALS) Postmortem Tissue: Neuroprotective or Neurotoxic Properties of Sirtuins in ALS?
Sonja Koerner et al.
NEURODEGENERATIVE DISEASES (2013)
The C9orf72 GGGGCC Repeat Is Translated into Aggregating Dipeptide-Repeat Proteins in FTLD/ALS
Kohji Mori et al.
SCIENCE (2013)
Characterization of a series of 4-aminoquinolines that stimulate caspase-7 mediated cleavage of TDP-43 and inhibit its function
Joel A. Cassel et al.
BIOCHIMIE (2012)
Region-specific changes in the immunoreactivity of SIRT1 expression in the central nervous system of SOD1G93A transgenic mice as an in vivo model of amyotrophic lateral sclerosis
Jae Chul Lee et al.
BRAIN RESEARCH (2012)
Loss of HDAC6, a novel CHIP substrate, alleviates abnormal tau accumulation
Casey Cook et al.
HUMAN MOLECULAR GENETICS (2012)
Inhibition of RNA lariat debranching enzyme suppresses TDP-43 toxicity in ALS disease models
Maria Armakola et al.
NATURE GENETICS (2012)
Nuclear accumulation of HDAC4 in ATM deficiency promotes neurodegeneration in ataxia telangiectasia
Jiali Li et al.
NATURE MEDICINE (2012)
Histone deacetylase (HDAC) inhibitors targeting HDAC3 and HDAC1 ameliorate polyglutamine-elicited phenotypes in model systems of Huntington's disease
Haiqun Jia et al.
NEUROBIOLOGY OF DISEASE (2012)
Identification of Epigenetically Altered Genes in Sporadic Amyotrophic Lateral Sclerosis
Claudia Figueroa-Romero et al.
PLOS ONE (2012)
Treatment with trichostatin A initiated after disease onset delays disease progression and increases survival in a mouse model of amyotrophic lateral sclerosis
Young-Eun Yoo et al.
EXPERIMENTAL NEUROLOGY (2011)
Neuroprotection by Histone Deacetylase-7 (HDAC7) Occurs by Inhibition of c-jun Expression through a Deacetylase-independent Mechanism
Chi Ma et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
The Dying-Back Phenomenon of Motor Neurons in ALS
Michal Dadon-Nachum et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2011)
Selective Toxicity by HDAC3 in Neurons: Regulation by Akt and GSK3β
Farah H. Bardai et al.
JOURNAL OF NEUROSCIENCE (2011)
HDAC1 and HDAC2 control the transcriptional program of myelination and the survival of Schwann cells
Claire Jacob et al.
NATURE NEUROSCIENCE (2011)
Protective effects of resveratrol through the up-regulation of SIRT1 expression in the mutant hSOD1-G93A-bearing motor neuron-like cell culture model of amyotrophic lateral sclerosis
Jing Wang et al.
NEUROSCIENCE LETTERS (2011)
Amyotrophic Lateral Sclerosis-associated Proteins TDP-43 and FUS/TLS Function in a Common Biochemical Complex to Co-regulate HDAC6 mRNA
Sang Hwa Kim et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Disease-causing mutations in Parkin impair mitochondrial ubiquitination, aggregation, and HDAC6-dependent mitophagy
Joo-Yong Lee et al.
JOURNAL OF CELL BIOLOGY (2010)
A Single-Dose Resveratrol Treatment in a Mouse Model of Amyotrophic Lateral Sclerosis
Chad D. Markert et al.
JOURNAL OF MEDICINAL FOOD (2010)
Differential Histone Deacetylase mRNA Expression Patterns in Amyotrophic Lateral Sclerosis
Claas Janssen et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2010)
Rational Design and Simple Chemistry Yield a Superior, Neuroprotective HDAC6 Inhibitor, Tubastatin A
Kyle V. Butler et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2010)
Phase 2 study of sodium phenylbutyrate in ALS
Merit E. Cudkowicz et al.
AMYOTROPHIC LATERAL SCLEROSIS (2009)
Combined riluzole and sodium phenylbutyrate therapy in transgenic amyotrophic lateral sclerosis mice
Steven J. Del Signore et al.
AMYOTROPHIC LATERAL SCLEROSIS (2009)
Randomized Sequential Trial of Valproic Acid in Amyotrophic Lateral Sclerosis
Sanne Piepers et al.
ANNALS OF NEUROLOGY (2009)
Arimoclomol: a potential therapy under development for ALS
Veena Lanka et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2009)
Epigenetic control of skull morphogenesis by histone deacetylase 8
Michael Haberland et al.
GENES & DEVELOPMENT (2009)
Variants of the elongator protein 3 (ELP3) gene are associated with motor neuron degeneration
Claire L. Simpson et al.
HUMAN MOLECULAR GENETICS (2009)
TDP-43 is recruited to stress granules in conditions of oxidative insult
Claudia Colombrita et al.
JOURNAL OF NEUROCHEMISTRY (2009)
LONG-TERM DIETARY ADMINISTRATION OF VALPROIC ACID DOES NOT AFFECT, WHILE RETINOIC ACID DECREASES, THE LIFESPAN OF G93A MICE, A MODEL FOR AMYOTROPHIC LATERAL SCLEROSIS
Cristophe Crochemore et al.
MUSCLE & NERVE (2009)
Muscle Mitochondrial Uncoupling Dismantles Neuromuscular Junction and Triggers Distal Degeneration of Motor Neurons
Luc Dupuis et al.
PLOS ONE (2009)
MicroRNA-206 Delays ALS Progression and Promotes Regeneration of Neuromuscular Synapses in Mice
Andrew H. Williams et al.
SCIENCE (2009)
Mutations in FUS, an RNA Processing Protein, Cause Familial Amyotrophic Lateral Sclerosis Type 6
Caroline Vance et al.
SCIENCE (2009)
Multiple roles of HDAC inhibition in neurodegenerative conditions
De-Maw Chuang et al.
TRENDS IN NEUROSCIENCES (2009)
Gcn5- and Elp3-induced histone H3 acetylation regulates hsp70 gene transcription in yeast
Qiuju Han et al.
BIOCHEMICAL JOURNAL (2008)
Histone deacetylase inhibitors: Therapeutic agents and research tools for deciphering motor neuron diseases
A. Echaniz-Laguna et al.
CURRENT MEDICINAL CHEMISTRY (2008)
HDAC6 is required for epidermal growth factor-induced β-catenin nuclear localization
Yu Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Maintenance of cardiac energy by histone deacetylase 3 metabolism in mice
Rusty L. Montgomery et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Mice lacking histone deacetylase 6 have hyperacetylated tubulin but are viable and develop normally
Yu Zhang et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
Induced ncRNAs allosterically modify RNA-binding proteins in cis to inhibit transcription
Xiangting Wang et al.
NATURE (2008)
Deregulation of HDAC1 by p25/Cdk5 in Neurotoxicity
Dohoon Kim et al.
NEURON (2008)
Paths of convergence: Sirtuins in aging and neurodegeneration
Li Gan et al.
NEURON (2008)
Combined lithium and valproate treatment delays disease onset, reduces neurological deficits and prolongs survival in an amyotrophic lateral sclerosis mouse model
H. -L. Feng et al.
NEUROSCIENCE (2008)
HDAC6 is a specific deacetylase of peroxiredoxins and is involved in redox regulation
R. B. Parmigiani et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
The deacetylase HDAC6 is a novel critical component of stress granules involved in the stress response
SoHee Kwon et al.
GENES & DEVELOPMENT (2007)
HDAC6 modulates cell motility by altering the acetylation level of cortactin
Xiaohong Zhang et al.
MOLECULAR CELL (2007)
Histone deacetylases 1 and 2 redundantly regulate cardiac morphogenesis, growth, and contractility
Rusty L. Montgomery et al.
GENES & DEVELOPMENT (2007)
HDAC6 rescues neurodegeneration and provides an essential link between autophagy and the UPS
Udai Bhan Pandey et al.
NATURE (2007)
Sodium valproate exerts neuroprotective effects in vivo through CREB-binding protein-dependent mechanisms but does not improve survival in an amyotrophic lateral sclerosis mouse model
Caroline Rouaux et al.
JOURNAL OF NEUROSCIENCE (2007)
The regulation of cyclin D1 degradation: roles in cancer development and the potential for therapeutic invention
John P. Alao
MOLECULAR CANCER (2007)
Trichostatin A increases SMN expression and survival in a mouse model of spinal muscular atrophy
Amy M. Avila et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
HDAC6 controls major cell response pathways to cytotoxic accumulation of protein aggregates
Cyril Boyault et al.
GENES & DEVELOPMENT (2007)
Induction of multiple heat shock proteins and neuroprotection in a primary culture model of familial amyotrophic lateral sclerosis
Zarah Batulan et al.
NEUROBIOLOGY OF DISEASE (2006)
Histone deacetylase 7 maintains vascular integrity by repressing matrix metalloproteinase 10
Shurong Chang et al.
CELL (2006)
Neuroprotection by histone deacetylase-related protein
BE Morrison et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Additive neuroprotective effects of a histone deacetylase inhibitor and a catalytic antioxidant in a transgenic mouse model of amyotrophic lateral sclerosis
S Petri et al.
NEUROBIOLOGY OF DISEASE (2006)
Amyotrophic lateral sclerosis associated with mutations in the CuZn superoxide dismutase gene
Peter M. Andersen
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2006)
Inhibition of histone deacetylase 6 acetylates and disrupts the chaperone function of heat shock protein 90 - A novel basis for antileukemia activity of histone deacetylase inhibitors
P Bali et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Sodium phenylbutyrate prolongs survival and regulates expression of anti-apoptotic genes in transgenic amyotrophic lateral sclerosis mice
H Ryu et al.
JOURNAL OF NEUROCHEMISTRY (2005)
Class II (IIa)-selective histone deacetylase inhibitors. 1. Synthesis and biological evaluation of novel (aryloxopropenyl)pyrrolyl hydroxyamides
A Mai et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Shaping the nuclear action of NF-κB
LF Chen et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2004)
A novel action of histone deacetylase inhibitors in a protein aggresome disease model
LJ Corcoran et al.
CURRENT BIOLOGY (2004)
Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man
LR Fischer et al.
EXPERIMENTAL NEUROLOGY (2004)
Histone deacetylases 5 and 9 govern responsiveness of the heart to a subset of stress signals and play redundant roles in heart development
SR Chang et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Benefit of valproic acid in suppressing disease progression of ALS model mice
F Sugai et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2004)
Histone deacetylase 4 controls chondrocyte hypertrophy during skeletogenesis
RB Vega et al.
CELL (2004)
Critical loss of CBP/p300 histone acetylase activity by caspase-6 during neurodegeneration
C Rouaux et al.
EMBO JOURNAL (2003)
The deacetylase HDAC6 regulates aggresome formation and cell viability in response to misfolded protein stress
Y Kawaguchi et al.
CELL (2003)
Developmental defects and p53 hyperacetylation in Sir2 homolog (SIRT1)-deficient mice
HL Cheng et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Essential function of histone deacetylase 1 in proliferation control and CDK inhibitor repression
G Lagger et al.
EMBO JOURNAL (2002)
HDAC6 is a microtubule-associated deacetylase
C Hubbert et al.
NATURE (2002)
From Charcot to Lou Gehrig: Deciphering selective motor neuron death in ALS
DW Cleveland et al.
NATURE REVIEWS NEUROSCIENCE (2001)
Signal-dependent nuclear export of a histone deacetylase regulates muscle differentiation
TA McKinsey et al.
NATURE (2000)
Share Paper
